Capsaicin - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for capsaicin and what is the scope of patent protection?

Capsaicin is the generic ingredient in one branded drug marketed by Averitas and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Capsaicin has sixty-seven patent family members in twenty-seven countries.

There are six drug master file entries for capsaicin. One supplier is listed for this compound.

Summary for capsaicin

International Patents:	67
US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	150
Clinical Trials:	196
Patent Applications:	6,470
Drug Prices:	Drug price trends for capsaicin
What excipients (inactive ingredients) are in capsaicin?	capsaicin excipients list
DailyMed Link:	capsaicin at DailyMed

See drug prices for capsaicin

See drug sales revenues for capsaicin

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for capsaicin

Generic Entry Date for capsaicin^: ⤷ Sign Up* Constraining patent/regulatory exclusivity: ⤷ Sign Up Dosage: PATCH;TOPICAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for capsaicin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University Hospital, Brest	Phase 2
Nantes University Hospital	Phase 3
Federal University of Minas Gerais	Phase 4

See all capsaicin clinical trials

Medical Subject Heading (MeSH) Categories for capsaicin

Antipruritics
Sensory System Agents

Anatomical Therapeutic Chemical (ATC) Classes for capsaicin

M02AB	Capsaicin and similar agents
M02A	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M	Musculo-skeletal system

N01BX	Other local anesthetics
N01B	ANESTHETICS, LOCAL
N01	ANESTHETICS
N	Nervous system

US Patents and Regulatory Information for capsaicin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for capsaicin

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009	⤷ Sign Up	⤷ Sign Up
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009	⤷ Sign Up	⤷ Sign Up
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009	⤷ Sign Up	⤷ Sign Up
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

EU/EMA Drug Approvals for capsaicin

Subscribe to access the full database, or Sign Up
Company	Drugname	Inn	Product Number / Indication	Status	Generic	Biosimilar	Orphan	Marketing Authorisation	Marketing Refusal
Grunenthal GmbH	Qutenza	capsaicin	EMEA/H/C/000909 Qutenza is indicated for the treatment of peripheral neuropathic pain in adults either alone or in combination with other medicinal products for pain.	Authorised	no	no	no	2009-05-15
>Company	>Drugname	>Inn	>Product Number / Indication	>Status	>Generic	>Biosimilar	>Orphan	>Marketing Authorisation	>Marketing Refusal

International Patents for capsaicin

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
China	102755305	Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer	⤷ Sign Up
Russian Federation	2349315	ТЕРАПЕВТИЧЕСКИЙ ПЛАСТЫРЬ С ПОЛИСИЛОКСАНОВОЙ МАТРИЦЕЙ, СОДЕРЖАЩЕЙ КАПСАИЦИН (THERAPEUTICAL PLASTER WITH POLYSILOXANE MATRIX CONTAINING CAPSAICIN)	⤷ Sign Up
Austria	363900		⤷ Sign Up
South Africa	200701138	Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.